Arkolith/Insider Trading/RGRX/Form 4

Goldstein Allan L

DirectorREGENERX BIOPHARMACEUTICALS INC (RGRX) · full profile →Form 4 · filed Jul 6, 2021
Net Buying
Open-Market Buys
$25K
Open-Market Sells
$0
Net Open-Market Flow
$25K
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 30, 2021Buy(P)125K$0.20$25K1.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 30, 2021Buy(P)94K—$094K
Jun 30, 2021Buy(P)94K—$094K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000914190-21-000192) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML